AI assistant
Sending…
HARROW, INC. — Director's Dealing 2018
Feb 8, 2018
31774_dirs_2018-02-08_bf9f5def-4d94-4fd4-af5a-8e9694b92d53.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 5 — Annual Statement of Changes in Beneficial Ownership
Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2017-12-31
Reporting Person: Longboard Capital Advisors, LLC (Institutional Investor)
Reporting Person: Conrad Brett (Managing Mbr of Longboard Cap.)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-03-21 | Common Stock | F | 52000 | $1.79 | Acquired | 1416000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-03-21 | Warrants | $1.79 | P | 52000 | Acquired | 2019-12-27 | Common Stock (52000) | Direct |
Footnotes
F1: $0.125/warrant; $1.915/unit (common stock and warrant)
More from HARROW, INC.
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 24
Regulatory Filings
2026
Mar 24
Director's Dealing
2026
Mar 3
Annual Report
2026
Mar 2
Regulatory Filings
2026
Mar 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 8